Article Versions Notes

O’Sullivan DE, Jarada TN, Yusuf A, Hu L, Gogna P, Brenner DR, Abbie E, Rose JB, Eaton K, Elia-Pacitti J, et al. Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers. Current Oncology. 2022; 29(10):7198-7208. https://doi.org/10.3390/curroncol29100567

O’Sullivan, Dylan E., Tamer N. Jarada, Amman Yusuf, Leo (Xun Yang) Hu, Priyanka Gogna, Darren R. Brenner, Erica Abbie, Jennifer B. Rose, Kiefer Eaton, Julia Elia-Pacitti, and et al. 2022. "Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers" Current Oncology 29, no. 10: 7198-7208. https://doi.org/10.3390/curroncol29100567

O’Sullivan, D. E., Jarada, T. N., Yusuf, A., Hu, L., Gogna, P., Brenner, D. R., Abbie, E., Rose, J. B., Eaton, K., Elia-Pacitti, J., Ewara, E. M., Pabani, A., Cheung, W. Y., & Boyne, D. J. (2022). Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers. Current Oncology, 29(10), 7198-7208. https://doi.org/10.3390/curroncol29100567